Printemps Paris integrates Alipay+ solutions to enable seamless digital payment experience for Asian customers
Printemps, the French luxury department store, announced today the integration of Alipay+, a suite of global cross-border digital payment and marketing solutions, to offer Asian consumers a convenient and seamless checkout experience with their home e-wallets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230706698291/en/
Printemps is among the first batch of major high-end retailers in France to leverage Alipay+ solutions for a smooth payment journey for consumers from Far East.
Through a simple integration, Kakao Pay and AlipayHK are now accepted at Printemps Paris, enabling Korean and Hong Kong shoppers to make payments using their most familiar payment app.
Besides Alipay, Kakao Pay and AlipayHK, Alipay+ also supports other partner e-wallets, including GCash (the Philippines), Touch ‘n Go eWallet (Malaysia), and TrueMoney (Thailand).
Printemps is among the first batch of major high-end retailers in France to leverage Alipay+ solutions for a smooth payment journey for consumers from Far East. For instance, Asian e-wallet users would experience a more transparent and real-time in-app display of their payments in both euro and their home currency.
Printemps will also leverage Alipay+ marketing solutions to engage consumers with a variety of shopping experiences and promotions through their payment apps. As part of the launch campaign, consumers can redeem a special reduction offer throughout summer 2023, with more perks and offers to follow in future.
The partnership with Alipay+ is expected to boost Printemps that stands as a prime spot for Asian tourists who seek a unique shopping experience. France was the top European destination for premium Asian consumers, and during the first six month of the year, France was the fifth most popular global destination for overseas Chinese travelers, according to Alipay statistics.
Printemps's collaboration with Ant Group began in 2015 when it added Alipay, China's leading payment app that serves over 1 billion consumers, to its accepted payment options. The pair partnered to introduce instant tax refund services to Alipay users for more convenience.
Developed by Ant Group, Alipay+ offers unified global mobile payment and marketing solutions that connect merchants with multiple e-wallets and payment methods. Consumers can conveniently use their preferred local payment methods while transacting seamlessly in a different market and are able to enjoy marketing offers from merchants through Alipay+.
"We have already been a pioneer with the successful integration of Alipay in 2015. Since 1865, Printemps has always been at the forefront of innovation so partnering with Alipay+ is a no-brainer for us,” said Emmanuel Suissa, Chief Partnership Officer at Printemps, “Alipay+ is a great new solution since it enables us to create 360-degree campaigns targeting the Asian market to engage customers on a regular basis, promote Printemps’ unique selling points, and encourage them to visit Paris and shop at Printemps."
“We are thrilled to put Alipay+ solutions at the service of a French company as emblematic as Printemps,” said Guoming Cheng, general manager of Ant Group in Europe and Middle East. “Aiming to help connect merchants across the globe and unleash new opportunities, we hope Alipay+ can bring out an A plus in the customer experience and commerce growth through innovation and digitalization.”
About Printemps
Founded in 1865 by Jules Jaluzot, the Printemps Group is a French leader in fashion, luxury, and beauty, with 20 department stores operated in France. The Group is also present in lifestyle with 9 Citadium stores and has become a key player in e-commerce with Place des Tendances, a fashion and beauty e-store acquired in 2013, and Made in Design, Europe's leading online store for designer furniture, lighting, and decoration, acquired in 2019. With more than 3,500 brands and a total area of 180,000 m², the Group employs 3,000 people driven by a unique passion for service. For more information, please visit https://us.printemps.com/ and @Printemps
About Alipay+
Alipay+ offers unified global mobile payment and marketing solutions that connect merchants with multiple e-wallets and payment methods from different countries and regions by collaborating with global partners. Consumers can conveniently use their preferred local payment methods while transacting seamlessly in a different market and be able to enjoy marketing offers by the merchants through Alipay+. Alipay+ is developed by Ant Group, the owner and operator of Alipay, one of the world’s leading digital open platforms.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230706698291/en/
Contact information
Sarah Dai
Ant Group
sarah.dai@antgroup.com
Zhang Ji
Printemps
jizhang@printemps.fr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release
Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release
HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom